Resveratrol derivatives: a patent review (2009 – 2012)

Author： Pezzuto John M   Kondratyuk Tamara P   Ogas Talysa  

Publisher： Informa Healthcare

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.23, Iss.12, 2013-12, pp. : 1529-1546

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Berberine and its derivatives: a patent review (2009 – 2012)

By Singh Inder Pal   Mahajan Shivani  

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 2, 2013-02 ,pp. : 215-231

Informa Healthcare

Access to resources Recommend Favorite

Acridine and its derivatives: a patent review (2009 – 2013)

By Zhang Bin   Li Xi   Li Bin   Gao Chunmei   Jiang Yuyang  

Expert Opinion on Therapeutic Patents, Vol. 24, Iss. 6, 2014-06 ,pp. : 647-664

Informa Healthcare

Access to resources Recommend Favorite

Acridine derivatives: a patent review (2009 –– 2010)

By Kaur Jatinder   Singh Palwinder  

Expert Opinion on Therapeutic Patents, Vol. 21, Iss. 4, 2011-04 ,pp. : 437-454

Informa Healthcare

Access to resources Recommend Favorite

New substituted benzimidazole derivatives: a patent review (2010 – 2012)

By Fei Fan   Zhou Zhiming  

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 9, 2013-09 ,pp. : 1157-1179

Informa Healthcare

Access to resources Recommend Favorite

Metalloenzyme inhibitors for the treatment of Gram-negative bacterial infections: a patent review (2009 - 2012)

By Supuran Claudiu T   Carta Fabrizio   Scozzafava Andrea  

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 7, 2013-07 ,pp. : 777-788

Informa Healthcare

Access to resources Recommend Favorite